Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Abnova™ FSTL3 (Human) ELISA Kit
In-vitro ELISA for the quantitative measurement of Human FSTL3
Supplier: Abnova™ KA1715
Includes:
- FLRG Microplate (Item A): coated with anti-huamn FLRG, 96 wells (12 strips x 8 wells)
- Wash Buffer Concentrate (20x) (Item B): 20x concentrated solution, 25mL
- Standards (Item C): recombinant human FLRG, 2 vials
- Assay Diluent C (Item L): diluent buffer. For Stand ard/Sample (serum/plasma samples/cell culture medium/urine) diluent, 30mL
- Assay Diluent B (Item E): 5x concentrated buffer. For detection antibody and HRP- Streptavidin diluent, 15mL
- Detection Antibody FLRG (Item F): biotinylated anti-human FLRG (each vial is enough to assay half microplate), 2 vials
- HRP-Streptavidin Concentrate (Item G): 240x concentrated HRP-conjugated streptavidin, 200μL
- TMB One-Step Substrate Reagent (Item H): 3, 3', 5, 5'-tetramethylbenzidine (TMB) in buffered solution, 12mL
- Stop Solution (Item I): 0.2M sulfuric acid, 8mL
Specifications
Biotin | |
FSTL3 (Human) ELISA Kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human FSTL3. | |
96 Antibody coated microwell, 25mL Wash Buffer 20X, 2 standard vials, 30mL assay diluent A, 15mL assay diluent B, 2 detection Antibody MSP vials, 8μL HRP Streptavidian concentrate, 12mL TMB one step Substrate reagent, 8mL stop solution | |
Cell Culture Supernatant, Plasma, Serum, Urine | |
Store the kit at -20°C. For best results, please store the components as described in the protocol. Avoid repeated freezing and thawing. | |
FSTL3 (Human) ELISA Kit |
Human | |
Colorimetric | |
96 Assays | |
100 μL | |
Quantification |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction